TrademarkDir
AIM BIOTECH
DEAD

Serial Number

88588339

Owner

AIM IMMUNOTECH INC.

Attorney

Donna J. Bunton

Filing Date

Aug 22, 2019

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

AIM BIOTECH Trademark

Serial Number: 88588339

AIM BIOTECH is a trademark filed by AIM IMMUNOTECH INC. on August 22, 2019. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

AIM IMMUNOTECH INC. (13 trademarks)

2117 SW HIGHWAY 484
OCALA, FL 34473

Entity Type: 03

HEMISPHERX BIOPHARMA, INC. (9 trademarks)

1617 JFK BLVD.
PHILADELPHIA, PA 19103

Entity Type: 03

Trademark Details

Filing Date

August 22, 2019

Registration Date

Not Registered

Published for Opposition

March 10, 2020

Goods & Services

Intravenous solution for use in the treatment of viral infections, immune disorders, cancer and ME/CFS; intravenous solution for use in the treatment of viral infections, immune disorders, cancer and ME/CFS; intravenous solution for use in the treatment of injuries resulting from surgery, thermal accidents or burns; Interferons; Parenterally administered interferon for use in treating viral diseases, immunological disorders and cancer; Pharmaceutical products, namely, pharmaceutical preparations for treatment of viral and infectious diseases, cancer, immune disorders and ME/CFS; intranasal solutions for use as a vaccine adjuvant

Pharmaceutical research and development; Pharmaceutical research and development of drugs for the treatment of cancers, viral diseases, immunological disorders and ME/CFS

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Jun 5, 2023 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Jun 5, 2023 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 3, 2022 EXRA
SOU EXTENSION 5 GRANTED
Nov 2, 2022 EX5G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Nov 2, 2022 AITU
SOU EXTENSION 5 FILED
Oct 25, 2022 EXT5
SOU TEAS EXTENSION RECEIVED
Oct 25, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 6, 2022 EXRA
SOU EXTENSION 4 GRANTED
May 4, 2022 EX4G
SOU EXTENSION 4 FILED
May 4, 2022 EXT4
SOU TEAS EXTENSION RECEIVED
May 4, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 6, 2021 EXRA
SOU EXTENSION 3 GRANTED
Nov 4, 2021 EX3G
SOU EXTENSION 3 FILED
Nov 4, 2021 EXT3
SOU TEAS EXTENSION RECEIVED
Nov 4, 2021 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 7, 2021 EXRA
SOU EXTENSION 2 GRANTED
May 5, 2021 EX2G
SOU EXTENSION 2 FILED
May 5, 2021 EXT2
SOU TEAS EXTENSION RECEIVED
May 5, 2021 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 7, 2020 EXRA
SOU EXTENSION 1 GRANTED
Nov 5, 2020 EX1G
SOU EXTENSION 1 FILED
Nov 5, 2020 EXT1
SOU TEAS EXTENSION RECEIVED
Nov 5, 2020 EEXT
ASSIGNED TO EXAMINER
Jul 23, 2020 DOCK
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
May 5, 2020 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 10, 2020 NPUB
PUBLISHED FOR OPPOSITION
Mar 10, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 19, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 31, 2020 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 4, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 3, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 3, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 25, 2019 GNRN
NON-FINAL ACTION E-MAILED
Nov 25, 2019 GNRT
NON-FINAL ACTION WRITTEN
Nov 25, 2019 CNRT
ASSIGNED TO EXAMINER
Nov 22, 2019 DOCK
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Oct 9, 2019 ASGN
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 6, 2019 NWOS
NEW APPLICATION ENTERED
Aug 26, 2019 NWAP

Related Trademarks

More from this Owner

ALFERON N INJECTION

ALFERON N INJECTION

ALFERON N INJECTION

ALFERON N INJECTION

AIM IMMUNOTECH logo

AIM IMMUNOTECH

AIM IMMUNOTECH logo

AIM IMMUNOTECH

AIM IMMUNOTECH logo

AIM IMMUNOTECH

AMPLIFIED IMMUNO MODULATION INC.

AMPLIFIED IMMUNO MODULATION INC.